Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by TCV Trust & Wealth Management Inc.

TCV Trust & Wealth Management Inc. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 5.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,245 shares of the medical equipment provider’s stock after selling 140 shares during the quarter. TCV Trust & Wealth Management Inc.’s holdings in Intuitive Surgical were worth $1,112,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Castleark Management LLC increased its stake in Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after buying an additional 2,990 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $454,000. Whalerock Point Partners LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $209,000. Tounjian Advisory Partners LLC purchased a new stake in Intuitive Surgical during the 1st quarter worth approximately $5,152,000. Finally, Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price target for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Get Our Latest Analysis on Intuitive Surgical

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.1%

NASDAQ:ISRG opened at $533.71 on Friday. The stock’s fifty day moving average is $532.08 and its two-hundred day moving average is $536.80. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The stock has a market capitalization of $191.29 billion, a price-to-earnings ratio of 78.26, a price-to-earnings-growth ratio of 5.67 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period last year, the firm earned $1.50 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.